PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
16-Jan-2024 Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference Theriva Biologics, Inc
16-Jan-2024 CellQuest launches Early Access Program with first CosyNest automated CAR-T manufacturing partner CellQuest
16-Jan-2024 Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year Phesi
16-Jan-2024 Modular automation solution adds PACE to just-in-time clinical trials packing CME Automation Systems
13-Jan-2024 Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner Avance Clinical
12-Jan-2024 HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status HUTCHMED
10-Jan-2024 Spago Nanomedical proceeds to the next dose level in the phase I/IIa study Tumorad-01 Spago Nanomedical AB (publ)
10-Jan-2024 Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma Ariceum Therapeutics
10-Jan-2024 AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union AbbVie
09-Jan-2024 CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry CD Biosciences
09-Jan-2024 STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety STEMart
09-Jan-2024 Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research Creative Diagnostics
09-Jan-2024 Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness Creative Diagnostics
09-Jan-2024 Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues Creative Diagnostics
05-Jan-2024 selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024 selectION, Inc.
14-Dec-2023 Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury Mission Therapeutics
14-Dec-2023 Levicept Completes Recruitment in Phase II Clinical Trial of Neurotrophin Modulator, LEVI-04 Levicept
14-Dec-2023 CellProthera advances towards its Phase III clinical trials with the development of a new potency assay CellProthera
14-Dec-2023 SiSaf Announces Completion of Patient Enrolment in Phase II Trial of Bio-Courier® Drug Formulation for the Treatment of Mild/Moderate Alopecia Areata SiSaf
14-Dec-2023 HUTCHMED Announces that it has Completed Enrollment of a Phase II/III Trial of Fruquintinib in Combination with Sintilimab for Advanced Renal Cell Carcinoma in China HUTCHMED